SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-016536
Filing Date
2022-11-07
Accepted
2022-11-07 09:46:14
Documents
45
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K rdhl-20220630x6k.htm   iXBRL 6-K 102255
2 EX-99.1 rdhl-20220630xex99d1.htm EX-99.1 443844
3 EX-99.2 rdhl-20220630xex99d2.htm   iXBRL EX-99.2 713369
4 GRAPHIC rdhl-20220630xex99d1001.jpg GRAPHIC 6435
  Complete submission text file 0001558370-22-016536.txt   4861594

Data Files

Seq Description Document Type Size
5 EX-101.SCH rdhl-20220630.xsd EX-101.SCH 66828
6 EX-101.CAL rdhl-20220630_cal.xml EX-101.CAL 51910
7 EX-101.DEF rdhl-20220630_def.xml EX-101.DEF 232016
8 EX-101.LAB rdhl-20220630_lab.xml EX-101.LAB 504684
9 EX-101.PRE rdhl-20220630_pre.xml EX-101.PRE 325994
39 EXTRACTED XBRL INSTANCE DOCUMENT rdhl-20220630x6k_htm.xml XML 658151
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 221364082
SIC: 2834 Pharmaceutical Preparations